Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis

Press/Media

Period	2 Oct 2018

Media coverage

Title Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis
Media name/outlet Clinical Trials.gov
Country/Territory United States
Date 2/10/18
Persons Ronald Hoffman

Title	Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis
Media name/outlet	Clinical Trials.gov
Country/Territory	United States
Date	2/10/18
Persons	Ronald Hoffman